BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ren Y, Wang Y, Li G, Zhang Z, Ma L, Cheng B, Chen J. Discovery of Novel Benzimidazole and Indazole Analogues as Tubulin Polymerization Inhibitors with Potent Anticancer Activities. J Med Chem 2021;64:4498-515. [PMID: 33788562 DOI: 10.1021/acs.jmedchem.0c01837] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Tian C, Wang M, Shi X, Chen X, Wang X, Zhang Z, Liu J. Discovery of (2-(pyrrolidin-1-yl)thieno[3,2-d]pyrimidin-4-yl)(3,4,5-trimethoxyphenyl)methanone as a novel potent tubulin depolymerizing and vascular disrupting agent. European Journal of Medicinal Chemistry 2022;238:114466. [DOI: 10.1016/j.ejmech.2022.114466] [Reference Citation Analysis]
2 Kumar N, Goel N. Recent development of imidazole derivatives as potential anticancer agents. Physical Sciences Reviews 2022;0. [DOI: 10.1515/psr-2021-0041] [Reference Citation Analysis]
3 Dhiman A, Sharma R, Singh RK. Target-based anticancer indole derivatives and insight into structure‒activity relationship: A mechanistic review update (2018–2021). Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.03.021] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Song J, Guan Y, Liu W, Song C, Tian X, Zhu T, Fu X, Qi Y, Zhang S. Discovery of novel coumarin-indole derivatives as tubulin polymerization inhibitors with potent anti-gastric cancer activities. European Journal of Medicinal Chemistry 2022;238:114467. [DOI: 10.1016/j.ejmech.2022.114467] [Reference Citation Analysis]
5 Feng LS, Su WQ, Cheng JB, Xiao T, Li HZ, Chen DA, Zhang ZL. Benzimidazole hybrids as anticancer drugs: An updated review on anticancer properties, structure-activity relationship, and mechanisms of action (2019-2021). Arch Pharm (Weinheim) 2022;:e2200051. [PMID: 35385159 DOI: 10.1002/ardp.202200051] [Reference Citation Analysis]
6 Shang Q, Tang H, Liu Y, Yin M, Su L, Xie S, Liu L, Yang W, Chen Y, Dong J, Zhou Y, Yin SF. Cu(i) catalysis for selective condensation/bicycloaromatization of two different arylalkynes: direct and general construction of functionalized C-N axial biaryl compounds. Chem Sci 2021;13:263-73. [PMID: 35059176 DOI: 10.1039/d1sc03865f] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Peng X, Li L, Chen J, Ren Y, Liu J, Yu Z, Cao H, Chen J. Discovery of Novel Histone Deacetylase 6 (HDAC6) Inhibitors with Enhanced Antitumor Immunity of Anti-PD-L1 Immunotherapy in Melanoma. J Med Chem 2022. [PMID: 35043615 DOI: 10.1021/acs.jmedchem.1c01863] [Reference Citation Analysis]
8 Liu X, Pang XJ, Liu Y, Liu WB, Li YR, Yu GX, Zhang YB, Song J, Zhang SY. Discovery of Novel Diarylamide N-Containing Heterocyclic Derivatives as New Tubulin Polymerization Inhibitors with Anti-Cancer Activity. Molecules 2021;26:4047. [PMID: 34279387 DOI: 10.3390/molecules26134047] [Reference Citation Analysis]
9 Ren Y, Ruan Y, Cheng B, Li L, Liu J, Fang Y, Chen J. Design, synthesis and biological evaluation of novel acridine and quinoline derivatives as tubulin polymerization inhibitors with anticancer activities. Bioorg Med Chem 2021;46:116376. [PMID: 34455231 DOI: 10.1016/j.bmc.2021.116376] [Reference Citation Analysis]
10 Cheng B, Zhu G, Meng L, Wu G, Chen Q, Ma S. Identification and optimization of biphenyl derivatives as novel tubulin inhibitors targeting colchicine-binding site overcoming multidrug resistance. Eur J Med Chem 2021;:113930. [PMID: 34794817 DOI: 10.1016/j.ejmech.2021.113930] [Reference Citation Analysis]
11 Satija G, Sharma B, Madan A, Iqubal A, Shaquiquzzaman M, Akhter M, Parvez S, Khan MA, Alam MM. Benzimidazole based derivatives as anticancer agents: Structure activity relationship analysis for various targets. Journal of Heterocyclic Chem 2022;59:22-66. [DOI: 10.1002/jhet.4355] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Yang B, Zhou J, Wang F, Hu XW, Shi Y. Pyrazoline derivatives as tubulin polymerization inhibitors with one hit for Vascular Endothelial Growth Factor Receptor 2 inhibition. Bioorg Chem 2021;114:105134. [PMID: 34246970 DOI: 10.1016/j.bioorg.2021.105134] [Reference Citation Analysis]